SAB Biotherapeutics, Inc. Profile Avatar - Palmy Investing

SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that…

Biotechnology
US, Sioux Falls [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of SABS's Analysis
CIK: 1833214 CUSIP: 78397T103 ISIN: US78397T2024 LEI: - UEI: -
Secondary Listings
SABS has no secondary listings inside our databases.